February 9, 2017 Life Science Tools PR/Corporate

10x Genomics Bolsters Commercial Leadership with the Appointment of Bradford J. Crutchfield as Chief Commercial Officer

PLEASANTON, Calif. – February 9, 2017 – 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced the appointment of Bradford J. Crutchfield as chief commercial officer of the company. Mr. Crutchfield will oversee global sales, marketing, business development and customer support. John Pouk, the company’s interim chief... Read more

February 8, 2017 Life Science Tools PR/Corporate

Swift Biosciences Expands Team, Hires Vice President of Marketing

Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development. “Candia‘s deep expertise in the genomic tools market and associated applications coupled to her incredibly strong track record with... Read more

February 8, 2017 Chromatography Environ, Ag./Food & Bev Lab Top-10 Product Launch

Phenomenex Publishes Comprehensive Food Testing Guide Featuring More Than 150 Applications

Torrance, CA (February 8, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of a new food testing guide to help the industry meet increasing demands for quality and safety testing and adhere to the guidelines of the Food Safety Modernization Act... Read more

February 7, 2017 Clinical Research/Diagn. M&A, Partnerships

AMETEK Acquires Rauland-Borg Corporation

BERWYN, Pa., Feb. 7, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Rauland-Borg Corporation, a leading global provider of mission critical communication solutions for hospitals, healthcare systems and educational facilities. Rauland-Borg was acquired for $340 million, plus a potential contingent payment of $30 million tied to the achievement... Read more

February 7, 2017 Bio/Pharma/CRO M&A, Partnerships

Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration

CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – 7 February 2017 –  The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize... Read more